• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

7,251
3,568
3,453
2,872
2,807

COUNTRY

2,401
894
277
269
231

CATEGORIES

  • 950
  • 175
    • 42
    • 253
    • 50
  • 114
  • 293
    • 48
  • 502
  • 257
  • 241
  • 58
  • 62
  • 848
  • 1,504
  • 823
  • 19
  • 495
  • 1,422
  • 2,387
    • 85
    • 124
    • 66
    • 65
    • 37
    • 36
    • 12
    • 12
    • 12
    • 18
  • 23
  • 269
  • 32
  • 2,624
SHOW ALL…

PRICE

2,551
8,049
16,654
29,187

PUBLISHED

2,515
6,980
12,472
29,187

PRODUCT TYPE

26,223
1,078
1,046
524
163
58
24
21
21
16
6
6
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE
Deep Vein Thrombosis (DVT)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Deep Vein Thrombosis (DVT)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Deep Vein Thrombosis (DVT)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Deep Vein Thrombosis (DVT)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the...

February 2015
FROM
Cysticercosis (Taeniasis)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Cysticercosis (Taeniasis)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Cysticercosis (Taeniasis)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Cysticercosis (Taeniasis)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the...

February 2015
FROM
Neuroblastoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Neuroblastoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Neuroblastoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Neuroblastoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Neuroblastoma....

February 2015
FROM
Mycoses-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Mycoses-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Mycoses-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Mycoses-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Mycoses. A key objective...

February 2015
FROM
Retinitis Pigmentosa (Retinitis)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Retinitis Pigmentosa (Retinitis)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Retinitis Pigmentosa (Retinitis)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Retinitis Pigmentosa (Retinitis)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across...

February 2015
FROM
Respiratory Hypersensitivity-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Respiratory Hypersensitivity-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Respiratory Hypersensitivity-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Respiratory Hypersensitivity-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across...

February 2015
FROM
Metastatic Brain Tumor-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Metastatic Brain Tumor-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Metastatic Brain Tumor-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Metastatic Brain Tumor-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Metastatic...

February 2015
FROM
Metabolic Acidosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Metabolic Acidosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Metabolic Acidosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Metabolic Acidosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Metabolic...

February 2015
FROM
Colon Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Colon Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Colon Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Colon Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Colon Cancer....

February 2015
FROM
Cirrhosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Cirrhosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Cirrhosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Cirrhosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Cirrhosis. A key...

February 2015
FROM
Seborrhea-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Seborrhea-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Seborrhea-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Seborrhea-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Seborrhea. A key...

February 2015
FROM
Obsessive-Compulsive Disorder-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Obsessive-Compulsive Disorder-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Obsessive-Compulsive Disorder-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Obsessive-Compulsive Disorder-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across...

February 2015
FROM
Acute Rheumatic Carditis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Acute Rheumatic Carditis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Acute Rheumatic Carditis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Acute Rheumatic Carditis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the...

February 2015
FROM
Acute Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Acute Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Acute Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Acute Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Acute Pain. A...

February 2015
FROM
Lyme Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Lyme Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Lyme Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Lyme Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Lyme Disease....

February 2015
FROM
Liver Transplantation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Liver Transplantation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Liver Transplantation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Liver Transplantation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Liver...

February 2015
FROM
Female Sexual Dysfunction-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Female Sexual Dysfunction-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Female Sexual Dysfunction-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Female Sexual Dysfunction-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the...

February 2015
FROM
Chlamydia Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Chlamydia Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Chlamydia Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Chlamydia Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Chlamydia...

February 2015
FROM
Lower Respiratory Tract Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Lower Respiratory Tract Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Lower Respiratory Tract Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Lower Respiratory Tract Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across...

February 2015
FROM
Lichen Simplex Chronicus (Neurodermatitis)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Lichen Simplex Chronicus (Neurodermatitis)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Lichen Simplex Chronicus (Neurodermatitis)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Lichen Simplex Chronicus (Neurodermatitis)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed...

February 2015
FROM
Loading Indicator

Our Clients

Pfizer, Inc. Grünenthal GmbH GlaxoSmithKline PLC Abbott Laboratories Ltd. Roche Diagnostics Ltd. Novo Nordisk A/S